Document is current
Any future updates will be listed below
-
Authors
Bhargava, Ramya https://orcid.org/0000-0001-7834-5453
Kalra, Philip A.
Hann, Mark
Brenchley, Paul
Hurst, Helen
Hutchison, Alastair J.
-
Funding
Funding for this research was provided by:
National Institute of Health Research (PB-PG-0711-25112)
- License Information
-
More Information
Article History
Received: 10 April 2018
Accepted: 17 January 2019
First Online: 4 February 2019
Ethics approval and consent to participate
: All trial procedures adhered to the Declaration of Helsinki and the trial protocol was reviewed and approved by the National Regional Ethics Committee East Midlands Derby, REC Ref No. 13/EM/0042. Written informed consent was obtained from all participants.
: Not applicable.
: Fifty percent of the study clinician’s salary was funded by an unrestricted educational grant from Shire pharmaceuticals. Prof Alastair J Hutchison and Prof Philip Kalra have been on the advisory committees for Shire pharmaceuticals and Amgen and heave been recipients of unrestricted research grants from these parties on different occasions. None of these companies had any input into the design or conduct of the trial. The results presented in this paper have not been published previously in whole or part, except in abstract format.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
